文献速递疼痛医学神经外科与老年麻醉

脊髓星形胶质细胞ZDHHC23介导GFAP棕榈酰化促进神经病理性疼痛

GFAP palmitoylcation mediated by ZDHHC23 in spinal astrocytes contributes to the development of neuropathic pain.
PubMed 文献 · Reg Anesth Pain Med · 2024-11-04

该研究在小鼠神经病理性癌痛模型中,发现脊髓背角星形胶质细胞活化后棕榈酰转移酶ZDHHC23表达上调,导致GFAP棕榈酰化水平增加及炎症因子分泌,进而通过STAT3通路正反馈激活星形胶质细胞;靶向GFAP棕榈酰化的竞争性肽可缓解癌痛信号、炎症因子分泌及吗啡耐受。

要点

  • 癌痛模型中脊髓星形胶质细胞ZDHHC23上调,GFAP棕榈酰化增加。
  • 炎症因子CXCL-10、IL-6、GM-CSF分泌增多,激活STAT3通路。
  • 靶向GFAP棕榈酰化可缓解癌痛及吗啡耐受。

核心结论

  • 在小鼠模型中,靶向GFAP棕榈酰化可有效缓解癌痛及吗啡耐受,但需人体转化研究验证。

研究设计与样本

  • 采用C57BL/6小鼠右侧坐骨神经周围接种S-180肉瘤细胞建立神经病理性癌痛模型,并使用小鼠星形胶质细胞系MA-C。

主要发现

  • 癌痛模型随肿瘤生长和外周神经侵袭,脊髓背角星形胶质细胞活化且ZDHHC23表达上调,GFAP棕榈酰化水平增加。
  • 炎症因子CXCL-10、IL-6和GM-CSF分泌增加,通过激活STAT3通路进一步激活星形胶质细胞。
  • 靶向GFAP棕榈酰化的竞争性肽可减轻癌痛信号、炎症因子分泌及吗啡耐受。

局限性

  • 研究仅基于啮齿类动物模型,结论需人体转化研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer pain has a significant impact on patient's quality of life. Astrocytes play an important role in cancer pain signaling. The direct targeting of astrocytes can effectively suppress cancer pain, however, they can cause many side effects. Therefore, there is an urgent need to identify the specific signaling pathways or proteins involved within astrocytes in cancer pain as targets for treating pain. METHODS: A neuropathic cancer pain (NCP) model was established by inoculating mouse S-180 sarcoma cells around the right sciatic nerve in C57BL/6 mice. Spontaneous persistent pain and paw withdrawal thresholds were measured using von Frey filaments. The NCP spinal cord dorsal horn (L4-L6) and mouse astrocyte cell line MA-C were used to study protein palmitoylation using acyl-biotin exchange, real-time polymerase chain reaction, ELISA, western blotting, and immunofluorescent staining. RESULTS: In a cancer pain model, along with tumor growth, peripheral nerve tissue invasion, and cancer pain onset, astrocytes in the dorsal horn of the spinal cord were activated and palmitoyltransferase ZDHHC23 expression was upregulated, leading to increased palmitoylation levels of GFAP and increased secretion of inflammatory factors, such as (C-X-C motif) ligand (CXCL)10 (CXCL-10), interleukin 6, and granulocyte-macrophage colony-stimulating factor. These factors in turn activate astrocytes by activating the signal transducer and activator of transcription 3 (STAT3) signaling pathway. A competitive peptide targeting GFAP palmitoylations was designed to effectively alleviate morphine tolerance in cancer pain treatment as well as cancer pain signaling and inflammatory factor secretion. CONCLUSIONS: In a rodent model, targeting GFAP palmitoylation appears to be an effective strategy in relieving cancer pain and morphine tolerance. Human translational research is warranted.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Fan X, Zhang S, Sun S, et al. GFAP palmitoylcation mediated by ZDHHC23 in spinal astrocytes contributes to the development of neuropathic pain. Reg Anesth Pain Med. 2024. PMID: 38050183. doi:10.1136/rapm-2023-104980

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。